Track topics on Twitter Track topics that are important to you
300 George Street
United States of America
Brokerages expect Achillion Pharmaceuticals to announce earnings of per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Achillion Pharm...
Achillion is handing out pink slips to 20 percent of its employees and initiating an operational restructuring plan.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes and Ladders—Achillion appoints Joseph Truitt CEO .Achillion appoints...
Achillion Pharmaceuticals, Inc. , a biopharmaceutical company focused on advancing oral small-molecule factor D inhibitors to modulate the complement alternative pathway, today announced the launch of...
According to Zacks, "Achillion generated no revenue in Q3 while loss was narrower than the estimates. The company has no approved product in its portfolio and focuses on developing small molecule ther...
The firm currently has $4.00 price objective on the biopharmaceutical company's stock. According to Zacks, "Achillion has no approved product in its portfolio and focuses on developing small molec...
NEW HAVEN: Achillion Pharmaceuticals [Nasdaq" ACHN] CEO Millind Deshpande is retiring and is being replaced by Joseph Truitt. Truitt had been named president and COO earlier in the year as the company...
Corporate restructuring expected to enable Achillion to focus on goal of advancing its clinical and late-stage preclinical portfolio while maintaining a strong balance sheet NEW HAVEN, Conn., Feb. 22,...
The purpose of this study is to determine the safety and antiviral HBV activity of ACH-126,443 (beta-L-Fd4C) in the treatment of Subjects of Previous Achillion-Sponsored Phase 1 and 2 Stud...
HIV-1 infected patients receiving long-term therapy with lamivudine or emtricitabine (nucleoside reverse transcriptase inhibitors [NRTIs]) are at risk for the development of a mutation at ...
Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced mult...
Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, ...
We have published hundreds of Achillion news stories on BioPortfolio along with dozens of Achillion Clinical Trials and PubMed Articles about Achillion for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achillion Companies in our database. You can also find out about relevant Achillion Drugs and Medications on this site too.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...